1. Home
  2. NEO vs CHCO Comparison

NEO vs CHCO Comparison

Compare NEO & CHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEO
  • CHCO
  • Stock Information
  • Founded
  • NEO 2001
  • CHCO 1957
  • Country
  • NEO United States
  • CHCO United States
  • Employees
  • NEO N/A
  • CHCO N/A
  • Industry
  • NEO Precision Instruments
  • CHCO Major Banks
  • Sector
  • NEO Health Care
  • CHCO Finance
  • Exchange
  • NEO Nasdaq
  • CHCO Nasdaq
  • Market Cap
  • NEO 1.9B
  • CHCO 1.7B
  • IPO Year
  • NEO 1999
  • CHCO N/A
  • Fundamental
  • Price
  • NEO $11.10
  • CHCO $117.19
  • Analyst Decision
  • NEO Strong Buy
  • CHCO Hold
  • Analyst Count
  • NEO 10
  • CHCO 3
  • Target Price
  • NEO $20.00
  • CHCO $118.00
  • AVG Volume (30 Days)
  • NEO 1.1M
  • CHCO 46.6K
  • Earning Date
  • NEO 02-18-2025
  • CHCO 01-23-2025
  • Dividend Yield
  • NEO N/A
  • CHCO 2.70%
  • EPS Growth
  • NEO N/A
  • CHCO 3.68
  • EPS
  • NEO N/A
  • CHCO 7.89
  • Revenue
  • NEO $660,566,000.00
  • CHCO $291,751,000.00
  • Revenue This Year
  • NEO $13.00
  • CHCO N/A
  • Revenue Next Year
  • NEO $10.74
  • CHCO $2.39
  • P/E Ratio
  • NEO N/A
  • CHCO $14.85
  • Revenue Growth
  • NEO 11.65
  • CHCO 1.79
  • 52 Week Low
  • NEO $10.69
  • CHCO $97.50
  • 52 Week High
  • NEO $19.11
  • CHCO $137.28
  • Technical
  • Relative Strength Index (RSI)
  • NEO 29.20
  • CHCO 43.53
  • Support Level
  • NEO $10.69
  • CHCO $117.04
  • Resistance Level
  • NEO $14.73
  • CHCO $122.62
  • Average True Range (ATR)
  • NEO 0.81
  • CHCO 2.63
  • MACD
  • NEO -0.19
  • CHCO 0.03
  • Stochastic Oscillator
  • NEO 10.15
  • CHCO 29.20

About NEO NeoGenomics Inc.

NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services.

About CHCO City Holding Company

City Holding Co is a financial holding company. It provides banking, trust and investment management, and other financial solutions through its network of banking offices located in the states of West Virginia, Virginia, southeastern Ohio, and Kentucky. It offers various products and services such as overdraft facilities, saving accounts, credit card and debit cards, loans for various purposes, investment advisory, securities brokerage, insurance, technology products, and others. These products and services are provided to commercial banking, consumer banking, mortgage banking, wealth management, and trust services.

Share on Social Networks: